Amitabh Biswas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amitabh Biswas has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Balram Bhargava
3 shared publicationsMitali Kapoor
3 shared publicationsSandeep Seth
3 shared publicationsSoumi Das
3 shared publicationsAnkit Verma
CSIR-Institute of Genomics and Integrative Biology, New Delhi, India
2 shared publications- Brajesh Kumar
Department of Forensic Sciences, School of Forensic Sciences, Galgotias University, Greater, India
2 shared publications
Latest Publications
- 7 October 2026
- Published by Springer Nature in The Science of Nature
- Vol. 113 (6) , 125
Allele frequency distribution and forensic efficiency parameters of 24 autosomal STR markers in the santhal tribal community of Bihar, India
- 7 October 2026
- Published by Springer Nature in The Science of Nature
- Vol. 113 (6) , 125
Allele frequency distribution and forensic efficiency parameters of 24 autosomal STR markers in the santhal tribal community of Bihar, India
- 11 September 2025
- Published by Taylor & Francis
- p. 322-350
Fluorescent Nanomaterials for Latent Fingerprints Detection
This chapter delves into the realm of latent fingerprint detection, focusing on the pivotal role of fluorescent nanomaterials in advancing fingerprint science. Beginning with an overview of latent fingerprint detection and the imperative for sophisticated methodologies in latent fingerprint science, the chapter highlights the significance of fluorescent nanomaterials in enhancing the quality of fingerprints in terms of contrast, sensitivity, and selectivity. The fundamental principles of fluorescence in the forensics fingerprints domain are elucidated, emphasizing the limitations of traditional methods and the advantages offered by fluorescent nanomaterials. The various types of fluorescent nanomaterials, including metal and metal oxide nanoparticles (NPs), semiconductor NPs, conjugated-polyelectrolyte dots, aggregation-based emission luminogens, quantum dots, carbon-based fluorescent NPs are covered, alongside their properties and applications in latent fingerprints development. The synthesis, functionalization strategies, mechanism of interaction, enhancement of fluorescence, as well as sensitivity of fluorescent nanomaterials tailored for latent fingerprint enhancement are also discussed. The chapter also provides insight into the state-of-the-art characterization methods for fluorescent nanomaterials, crucial for understanding their structural and optical properties in the context of latent fingerprint detection. It provides a comprehensive overview of nanomaterials, covering principles, types, synthesis, applications, challenges, and future perspectives while integrating fingerprint science fundamentals to ensure accessibility for both fundamental science and layman readers.
- 11 September 2025
- Published by Taylor & Francis
- p. 322-350
Fluorescent Nanomaterials for Latent Fingerprints Detection
This chapter delves into the realm of latent fingerprint detection, focusing on the pivotal role of fluorescent nanomaterials in advancing fingerprint science. Beginning with an overview of latent fingerprint detection and the imperative for sophisticated methodologies in latent fingerprint science, the chapter highlights the significance of fluorescent nanomaterials in enhancing the quality of fingerprints in terms of contrast, sensitivity, and selectivity. The fundamental principles of fluorescence in the forensics fingerprints domain are elucidated, emphasizing the limitations of traditional methods and the advantages offered by fluorescent nanomaterials. The various types of fluorescent nanomaterials, including metal and metal oxide nanoparticles (NPs), semiconductor NPs, conjugated-polyelectrolyte dots, aggregation-based emission luminogens, quantum dots, carbon-based fluorescent NPs are covered, alongside their properties and applications in latent fingerprints development. The synthesis, functionalization strategies, mechanism of interaction, enhancement of fluorescence, as well as sensitivity of fluorescent nanomaterials tailored for latent fingerprint enhancement are also discussed. The chapter also provides insight into the state-of-the-art characterization methods for fluorescent nanomaterials, crucial for understanding their structural and optical properties in the context of latent fingerprint detection. It provides a comprehensive overview of nanomaterials, covering principles, types, synthesis, applications, challenges, and future perspectives while integrating fingerprint science fundamentals to ensure accessibility for both fundamental science and layman readers.
- 1 April 2022
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 10 (4)
Understanding Musculoskeletal Disorders Through Next-Generation Sequencing
» An insight into musculoskeletal disorders through advancements in next-generation sequencing (NGS) promises to maximize benefits and improve outcomes through improved genetic diagnosis. » The primary use of whole exome sequencing (WES) for musculoskeletal disorders is to identify functionally relevant variants. » The current evidence has shown the superiority of NGS over conventional genotyping for identifying novel and rare genetic variants in patients with musculoskeletal disorders, due to its high throughput and low cost. » Genes identified in patients with scoliosis, osteoporosis, osteoarthritis, and osteogenesis imperfecta using NGS technologies are listed for further reference.
- 1 April 2022
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 10 (4)
Understanding Musculoskeletal Disorders Through Next-Generation Sequencing
» An insight into musculoskeletal disorders through advancements in next-generation sequencing (NGS) promises to maximize benefits and improve outcomes through improved genetic diagnosis. » The primary use of whole exome sequencing (WES) for musculoskeletal disorders is to identify functionally relevant variants. » The current evidence has shown the superiority of NGS over conventional genotyping for identifying novel and rare genetic variants in patients with musculoskeletal disorders, due to its high throughput and low cost. » Genes identified in patients with scoliosis, osteoporosis, osteoarthritis, and osteogenesis imperfecta using NGS technologies are listed for further reference.
- 31 May 2019
- Published by Springer Nature in Purinergic Signalling
- Vol. 15 (2) , 205-210
Loss of function mutation in the P2X7, a ligand-gated ion channel gene associated with hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is an inherited heart failure condition, mostly found to have genetic abnormalities, and is a leading cause of sudden death in young adults. Whole exome sequencing should be given consideration as a molecular diagnostic tool to identify disease-causing mutation/s. In this study, a HCM family with multiple affected members having history of sudden death were subjected to exome sequencing along with unaffected members. Quality passed variants obtained were filtered for rarity (MAF > 0.5%), evolutionary conservation, pathogenic prediction, and segregation in affected members after removing shared variants present in unaffected members. Only one non-synonymous mutation (p. Glu186Lys or E186K) in exon 6 of P2X7 gene segregated in HCM-affected individuals which was absent in unaffected family members and 100 clinically evaluated controls. The site of the mutation is highly conserved and led to complete loss of function which is in close vicinity to ATP-binding site-forming residues, affecting ATP binding, channel gating, or both. Mutations in candidate genes which were not segregated define clinical heterogeneity within affected members. P2X7 gene is highly expressed in the heart and shows direct interaction with major candidate genes for HCM. Our results reveal a significant putative HCM causative gene, P2X7, for the first time and show that germ-line mutations in P2X7 may cause a defective phenotype, suggesting purinergic receptor involvement in heart failure mediated through arrhythmias which need further investigations to be targeted for therapeutic interventions.
- 31 May 2019
- Published by Springer Nature in Purinergic Signalling
- Vol. 15 (2) , 205-210
Loss of function mutation in the P2X7, a ligand-gated ion channel gene associated with hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is an inherited heart failure condition, mostly found to have genetic abnormalities, and is a leading cause of sudden death in young adults. Whole exome sequencing should be given consideration as a molecular diagnostic tool to identify disease-causing mutation/s. In this study, a HCM family with multiple affected members having history of sudden death were subjected to exome sequencing along with unaffected members. Quality passed variants obtained were filtered for rarity (MAF > 0.5%), evolutionary conservation, pathogenic prediction, and segregation in affected members after removing shared variants present in unaffected members. Only one non-synonymous mutation (p. Glu186Lys or E186K) in exon 6 of P2X7 gene segregated in HCM-affected individuals which was absent in unaffected family members and 100 clinically evaluated controls. The site of the mutation is highly conserved and led to complete loss of function which is in close vicinity to ATP-binding site-forming residues, affecting ATP binding, channel gating, or both. Mutations in candidate genes which were not segregated define clinical heterogeneity within affected members. P2X7 gene is highly expressed in the heart and shows direct interaction with major candidate genes for HCM. Our results reveal a significant putative HCM causative gene, P2X7, for the first time and show that germ-line mutations in P2X7 may cause a defective phenotype, suggesting purinergic receptor involvement in heart failure mediated through arrhythmias which need further investigations to be targeted for therapeutic interventions.
- 8 June 2014
- Published by Springer Nature in Molecular Biology Reports
- Vol. 41 (8) , 4881-4888
Next generation sequencing in cardiomyopathy: towards personalized genomics and medicine
Next generation sequencing (NGS) is perhaps one of the most exciting advances in the field of life sciences and biomedical research in the last decade. With the availability of massive parallel sequencing, human DNA blueprint can be decoded to explore the hidden information with reduced time and cost. This technology has been used to understand the genetic aspects of various diseases including cardiomyopathies. Mutations for different cardiomyopathies have been identified and cataloging mutations on phenotypic basis are underway and are expected to lead to new discoveries that may translate to novel diagnostic, prognostic and therapeutic targets. With ease in handling NGS, cost effectiveness and fast data output, NGS is now considered as a diagnostic tool for cardiomyopathy by providing targeted gene sequencing. In addition to the number of genetic variants that are identified in cardiomyopathies, there is a need of quicker and easy way to screen multiple genes associated with the disease. In this review, an attempt has been made to explain the NGS technology, methods and applications in cardiomyopathies and their perspective in clinical practice and challenges which are to be addressed.
- 8 June 2014
- Published by Springer Nature in Molecular Biology Reports
- Vol. 41 (8) , 4881-4888
Next generation sequencing in cardiomyopathy: towards personalized genomics and medicine
Next generation sequencing (NGS) is perhaps one of the most exciting advances in the field of life sciences and biomedical research in the last decade. With the availability of massive parallel sequencing, human DNA blueprint can be decoded to explore the hidden information with reduced time and cost. This technology has been used to understand the genetic aspects of various diseases including cardiomyopathies. Mutations for different cardiomyopathies have been identified and cataloging mutations on phenotypic basis are underway and are expected to lead to new discoveries that may translate to novel diagnostic, prognostic and therapeutic targets. With ease in handling NGS, cost effectiveness and fast data output, NGS is now considered as a diagnostic tool for cardiomyopathy by providing targeted gene sequencing. In addition to the number of genetic variants that are identified in cardiomyopathies, there is a need of quicker and easy way to screen multiple genes associated with the disease. In this review, an attempt has been made to explain the NGS technology, methods and applications in cardiomyopathies and their perspective in clinical practice and challenges which are to be addressed.
- 1 November 2013
- Published by Elsevier in Journal of Affective Disorders
- Vol. 151 (2) , 673-678
High rate of suicide attempt and associated psychological traits in an isolated tribal population of North-East India
- 1 November 2013
- Published by Elsevier in Journal of Affective Disorders
- Vol. 151 (2) , 673-678
High rate of suicide attempt and associated psychological traits in an isolated tribal population of North-East India